NCT05983068 - A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 22, 2024

Primary Completion Date

May 29, 2026

Study Completion Date

August 7, 2026

Conditions

Dermatitis Atopic

Interventions

DRUG

dupilumab

solution for injection; by subcutaneous (SC) injection

Trial Locations (4)

NYU Langone Medical Center- Site Number : 8400004, New York

SSM Health Saint Louis University Hospital- Site Number : 8400006, St Louis

National Jewish Health Medical Center- Site Number : 8400001, Denver

Investigational Site Number : 8260001, Sheffield